Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hiroko Ohizumi"'
Autor:
Masao Saitoh, Hiromi Sakata, Motoki Yonekawa, Tohru Tamaki, Jun-ichi Meguro, Naoyuki Kawamura, Kazutaka Kukita, Akio Kawamura, Takashi Horie, Hiroko Ohizumi
Publikováno v:
Therapeutic Apheresis and Dialysis. 7:536-539
Ulcerative colitis is a chronic inflammatory disease of the rectum and colon. Although the pathogenesis of ulcerative colitis is not fully elucidated, cell-mediated immunity plays an important role in disease pathogenesis. Leukocytapheresis is a newl
Autor:
Motoki Yonekawa, Kazutaka Kukita, Masao Saitoh, Hiroko Ohizumi, Akio Kawamura, Tohru Tamaki, Takashi Horie, Jun-ichi Meguro
Publikováno v:
Therapeutic Apheresis. 3:334-337
Leukocytapheresis (LCAP) is widely used for the treatment of immunological diseases. We studied a new treatment of LCAP using a nonwoven polyester fiber filter. In a basic study, 30–70% of leukocytes were removed. Also, 30–68% of the leukocyte su
Autor:
Masahiro Asaka, Naoki Kobayashi, Yoshio Kiyama, Masaharu Kasai, Satoshi Hashino, Junji Tanaka, Masahiro Ogasawara, Tohru Naohara, Gak Suzuki, Masahiro Imamura, Nobuo Masauzi, Toshio Higa, Hiroko Ohizumi, Masao Saitoh
Publikováno v:
Leukemia & Lymphoma. 27:357-363
We report a case of B-cell acute lymphocytic leukemia which showed histological transformation from an FAB-L2 into a Burkitt's type (FAB-L3). Both leukemias had identical immunoglobulin heavy-chain joining gene and kappa light-chain joining gene rear
Autor:
Akio Kawamura, Hiroko Ohizumi, Masao Saito, Toru Tamaki, Motoki Yonekawa, Masahiro Asaka, Hiroshi Takeda, Souichi Nakagawa, Jun Nishihira, Tatsuya Ohkawara
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 11(2)
Ulcerative colitis (UC) is characterized by chronic inflammation of the colon and its cause and pathogenesis have not been fully clarified. Although UC is treated with various drugs, including 5-amino-salycilate and glucocorticoids, some patients are
Autor:
Tohru Naohara, Tamotsu Miyazaki, Toshio Higa, Yoshio Kiyama, Masahiro Imamura, Hiroko Ohizumi, Masaharu Kasai, Junji Tanaka, Masao Saitoh, Ken Morii, Nobuo Masauzi, Keisuke Sakurada, Atsushi Matsuura
Publikováno v:
British Journal of Haematology. 86:436-438
Summary We assessed the origin of bone marrow derived fibroblastoid cells (BMF) in long-term cultures of 13 samples obtained from nine patients after allo-BMT by polymerase chain reaction (PCR) amplification of MCT118, one of the variable number of t
Autor:
Satoshi Yuuki, Yu Sakata, Takuto Miyagishima, Yoshito Komatsu, Maso Watanabe, Takashi Kato, Yasuyuki Kunieda, Takashi Meguro, Nozomu Fuse, Masaaki Takei, Hirotoshi Akita, Masahiro Asaka, Hiroko Ohizumi, Miki Tateyama, Osamu Wakahama, Mineo Kudo
Publikováno v:
Japanese Journal of Clinical Oncology. 35:88-89
We have previously reported on phase I/II studies of irinotecan plus S-1 therapy for advanced gastric cancer. Based on the safety and efficacy data that were obtained, this phase II study was planned to assess the efficacy of irinotecan plus S-1 for
Autor:
Tohru Naohara, Toshio Higa, Masaharu Kasai, Masahiro Imamura, Masao Saitho, Nobuo Masauzi, Atsushi Matsuura, Tamotsu Miyazaki, Shinsei Gasa, Junji Tanaka, Keisuke Sakurada, Koichi Honke, Yoshio Kiyama, Hiroko Ohizumi, Ken Morii
Publikováno v:
British journal of haematology. 85(3)
Cytokine gene expression in peripheral blood mononuclear cells during the development of graft-versus-host disease (GVHD) in patients who underwent allogeneic bone marrow transplantation (allo BMT) was analysed using a semiquantitative reverse-transc
Autor:
Masanobu Kobayashi, Ryosuke Soga, Yuuji Tsuda, Mihiro Okabe, Hiroshi Iwasaki, Manabu Musashi, Masahiro Imamura, Masaharu Kasai, Hiroko Ohizumi, Sugiura M, Keisuke Sakurada, Shiro Maeda, Masanobu Morioka, Tamotsu Miyazaki
Publikováno v:
British journal of haematology. 82(1)
A novel human myeloid cell line, designated HSM-1, has been established from the pleural effusion of a patient with granulocytic sarcoma (GS) who had been followed as having primary myelofibrosis for 10 years. When he was diagnosed as having granuloc